Opportunity Overview
Modification SPE2D224D0003 P00002 to exercise Option Year 1 effective February 12, 2025 through February 11, 2026.
Modification SPE2D224D0003 P00001 to incorporate FAR 52.204-30 Federal Acquisition Supply Chain Security Act Orders language into solicitation for subject contract.
Modification SPE2D224D0003 P00001 to incorporate FAR 52.204-30 Federal Acquisition Supply Chain Security Act Orders language into solicitation for subject contract.
This is one of 124 active United States Pharmaceuticals opportunities most of your competitors will never see.
Your competitors are watching the same crowded contracts everyone else is. Track this opportunity and every one like it worldwide, set deadline alerts, and win where they aren’t. Free for 14 days, no card.
Start FreeSolicitation Details
| Issuing agency | Dept of Defense |
|---|---|
| Country | United States |
| Category | Pharmaceuticals |
| Estimated value | $7.0M |
| NAICS | 325412 |
| PSC | 6505 |
| Published | February 05, 2025 |
| Procurement stage | Request for Proposal (RFP) |
| Response due | February 12, 2029 |
| Status | Open — accepting responses |
| Official source | View original notice |
| Last verified | August 09, 2026 |
Source: U.S. Government (SAM.gov) — public domain. GlobalGov is not affiliated with or endorsed by the United States Government.
Related Opportunities in United States
See every United States Pharmaceuticals opportunity your competition is missing. Free for 14 days.
Get real-time alerts, competitive intelligence, and deadline tracking for this and every market worldwide.
Start Free Trial — No Card RequiredFree 14-day trial · no card required
See who is already competing here →Get a free United States Pharmaceuticals intelligence report in your inbox
A personalized report on United States Pharmaceuticals opportunities, emailed in 5-10 minutes. One per month, no account needed.